Dr Lal PathLabs adds Illumina’s NovaSeq X to its genomics division
The NovaSeq X system, featuring Illumina’s XLEAP-SBS chemistry, can generate more than 20,000 whole genomes per year, more than…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Dr Lal Pathlabs
Dr Lal PathLabs launch advanced test for Amyloidosis
Samples can be collected from anywhere in India and sent to the National Reference Lab, Rohini, New Delhi, for testing
Dr Lal PathLabs records revenue of Rs 541 Cr in Q1 FY 2023-24
PAT margin for Q1 FY24 is 15.4 per cent
Suburban Diagnostics unveils its new reference laboratory in Mumbai
Suburban Diagnostics is present in Mumbai and has expanded its footprint in Pune, and several parts of Maharashtra, Goa, and…
IIMA collaborates with Lal Pathlabs Foundation to set up research chair in healthcare
The objective of the Dr Lal Pathlabs Chair in Healthcare is to complement the Institute’s existing research being done by its…
- Advertisement -
COVID-19 contributes 17 per cent to Dr Lal PathLabs Q2 FY21 revenues
Clocks 18.2 per cent hike in Q2 FY 2020-21 operating revenues over same quarter last year
The triple economic burden faced by the healthcare industry
Hony) Brig Dr Arvind Lal, Adviser, FICCI Health Services Committee and Executive Chairman, Dr Lal PathLabs shares his views on the…
Dr Lal PathLabs board approves acquisition of 70 per cent stake in new company
The new company will be engaged in healthcare/diagnostic services in Madhya Pradesh and adjoining areas
Dr Lal PathLabs collaborates with ORDI to sensitise India on rare diseases
The association is to raise awareness for the 7,000 documented rare diseases across nine cities
NITI Aayog and NHA reassure FICCI’s health sector leadership on sustainable partnerships for…
FICCI presented its policy recommendations on the key tenets for implementation of AB-PMJAY for strengthening the number of…